Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nirup Krishnamurthy Insider Profile
4 Followers
Nirup Krishnamurthy, CEO, Director at Medicine Man Technologies, holds 1.62M shares in Medicine Man Technologies (Ticker: SHWZ).
Nirup Krishnamurthy has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Nirup Krishnamurthy's holdings
Insider Roles
CEO, Director
Roles that Nirup Krishnamurthy holds in companies
Most Profitable Insider Trade
The most profitable trade made by Nirup Krishnamurthy
Nirup Krishnamurthy's Trading History
List of latest transactions for each holding click on a transaction to see Nirup Krishnamurthy's performance on stock
You May Also Like
Nirup Krishnamurthy insider profile FAQ
What is the percentage of profitable transactions made by Nirup Krishnamurthy?
The percentage of profitable transactions made by Nirup Krishnamurthy is ―.
What is the average return per transaction made by Nirup Krishnamurthy?
The average return per transaction made by Nirup Krishnamurthy is ―.
What stocks does Nirup Krishnamurthy hold?
Nirup Krishnamurthy holds: SHWZ stocks.
What was Nirup Krishnamurthy’s latest transaction?
Nirup Krishnamurthy latest transaction was an Uninformative Buy of $3.83K.
What was Nirup Krishnamurthy's most profitable transaction?
Nirup Krishnamurthy’s most profitable transaction was an Informative Buy of SHWZ stock on January 16, 2024. The return on the trade was -21.70%.
What is Nirup Krishnamurthy's role in Medicine Man Technologies?
Nirup Krishnamurthy's role in Medicine Man Technologies is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.